As sure as the sun rises, prescription medicine use and total drug spending continue to increase in the U.S. | Last year's ...

For the full year, the net loss was $20.8M, or $1.93 per ... Lantern Pharma's Q4 2024 earnings call underscored its advancements in precision oncology and AI-driven drug development.